Influenza in immunocompromised patients: considerations for therapy

ISSN： 1746-0794

Source： Future Virology, Vol.6, Iss.7, 2011-07, pp. : 855-868

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oseltamivir/peramivir: Development of oseltamivir and peramivir resistance in influenza A infection, in immunocompromised patients: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1309, 2010-01 ,pp. : 31-31

Adis International

Access to resources Recommend Favorite

Immunosuppressive Therapy for Paediatric Transplant Patients: Pharmacokinetic Considerations

By Fernández de Gatta M.d.M.

Clinical Pharmacokinetics, Vol. 41, Iss. 2, 2002-01 ,pp. : 115-135

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Considerations for Antimicrobial Therapy in Patients Receiving Renal Replacement Therapy

By Pea Federico

Clinical Pharmacokinetics, Vol. 46, Iss. 12, 2007-01 ,pp. : 997-1038

Adis International

Access to resources Recommend Favorite

Cytomegalovirus treatment options in immunocompromised patients

By Sharland Mike Khare Milind D

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 8, 2001-08 ,pp. : 1247-1257

Informa Healthcare

Access to resources Recommend Favorite

Neuraminidase Inhibitors in Pediatric Patients: Potential Place in Influenza Therapy

By Noyola D.E.

Pediatric Drugs, Vol. 5, Iss. 2, 2003-01 ,pp. : 125-131

Adis International

Access to resources Recommend Favorite